MariMed Inc.
corporate_fare Company Profile
MariMed Inc. (OTC:MRMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for MRMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for MRMD spans 10-Q, 8-K, DEF 14A, PRE 14A.
Recent high-impact activity:
- MariMed 10-Q: Record $44.2M Q3 Revenue, But Net Loss Widens to $3.5M
- MariMed Q3 Revenue Hits $44.2M, Adjusted EBITDA $4.7M as Net Loss Widens
- MariMed Holders Approve 1-for-50 to 1-for-100 Reverse Split; Board Undecided on Timing
- MariMed Sets October 28 Vote on 1-for-50 to 1-for-100 Reverse Split to Enable Uplisting
- MariMed Seeks Shareholder Approval for 1-for-50 to 1-for-100 Reverse Stock Split to Enable Uplisting
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 18,486 shares in MRMD as of the October 30, 2026 settlement, a 1748.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 74.3% of MRMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.